Skip to Main content

Press Release

CEO Paul Tufano Presents at J.P. Morgan Healthcare Conference

January 13, 2017
Philadelphia, Pa.

Paul A. Tufano, Chairman and Chief Executive Officer, AmeriHealth Caritas

On Monday, January 9, our CEO Paul Tufano presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. The J.P. Morgan event is one of the largest and most influential health conferences in the world, attended by more than 10,000 leaders in health care, biotech, and finance.

Paul told the story of our mission-based beginnings in West Philadelphia, and our steady, quality-focused expansion over the last three decades. The audience learned about our multiple highest and top ratings by the National Committee for Quality Assurance (NCQA), our impressive new business and growth trajectory, and our integrated model of care that allows us to provide quality health care and services to those most in need.

"I was so proud to share the inspiring work of our associates being performed across our family of companies," said Tufano. "We have established AmeriHealth Caritas as a national leader and, now more than ever, others are looking to us as a model organization founded on mission, focused on quality, and committed to continued investment in the health and wellness of our fellow Americans."

About AmeriHealth Caritas

AmeriHealth Caritas is part of the Independence Health Group in partnership with Blue Cross Blue Shield of Michigan. AmeriHealth Caritas is one of the nation’s leaders in health care solutions for those most in need. Operating in 18 states and the District of Columbia, AmeriHealth Caritas serves more than 5.7 million Medicaid, Medicare, and CHIP members through its integrated managed care products, pharmaceutical benefit management and specialty pharmacy services, behavioral health services, and other administrative services. Headquartered in Philadelphia, AmeriHealth Caritas is a mission-driven organization with more than 30 years of experience serving low-income and chronically ill populations. For more information, visit